3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
5
Breast Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Transitional Cell
3
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Prostatic Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lung Neoplasms
1
Lung Diseases
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Liver Failure
1
HRD Cancer
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Drug-Related Side Effects and Adverse Reactions
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Gemcitabine
26
Specimen Handling
20
130-nm albumin-bound paclitaxel
18
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Biopsy
12
Fluorouracil
11
Leucovorin
10
Oxaliplatin
9
Cyclophosphamide
8
pembrolizumab
7
fludarabine
7
Albumin-Bound Paclitaxel
7
Cisplatin
6
Cetuximab
6
Nivolumab
5
durvalumab
4
Taxes
4
Radiosurgery
4
Pemetrexed
4
Capecitabine
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
dehydroftorafur
3
aldesleukin
3
Radiotherapy
3
Immunoglobulin G
3
Exercise
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
sacituzumab govitecan
×
30 days
×
Clear all
No trials found.